ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 396 filers reported holding ENCOMPASS HEALTH CORP in Q2 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $427 | -3.0% | 6,356 | -2.3% | 0.00% | 0.0% |
| Q2 2023 | $440 | +25.7% | 6,504 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $350 | -29.3% | 6,473 | -21.8% | 0.00% | -33.3% |
| Q4 2022 | $495 | -99.8% | 8,279 | +66.9% | 0.00% | +200.0% |
| Q3 2022 | $224,000 | -11.8% | 4,960 | +9.3% | 0.00% | 0.0% |
| Q2 2022 | $254,000 | -20.1% | 4,537 | +1.3% | 0.00% | 0.0% |
| Q1 2022 | $318,000 | +55.1% | 4,477 | +39.7% | 0.00% | -50.0% |
| Q1 2020 | $205,000 | -18.3% | 3,204 | -11.5% | 0.00% | 0.0% |
| Q4 2019 | $251,000 | -52.9% | 3,621 | -58.0% | 0.00% | -66.7% |
| Q4 2018 | $533,000 | +51.4% | 8,631 | +90.9% | 0.01% | +100.0% |
| Q3 2018 | $352,000 | +16.9% | 4,521 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $301,000 | +22.9% | 4,445 | +3.6% | 0.00% | 0.0% |
| Q1 2018 | $245,000 | – | 4,291 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANA PARTNERS LLC | 2,001,897 | $150,222,000 | 11.74% |
| JET CAPITAL INVESTORS L P | 855,100 | $64,167,000 | 10.95% |
| Davide Leone & Partners Investment Co Ltd. | 735,308 | $55,178,000 | 4.23% |
| Kent Lake Capital LLC | 110,000 | $8,254,000 | 3.55% |
| REINHART PARTNERS, LLC. | 604,274 | $53,309,000 | 2.71% |
| AREX Capital Management, LP | 74,000 | $5,553,000 | 2.59% |
| RK Capital | 179,800 | $13,492,000 | 2.55% |
| Orchard Capital Management, LLC | 108,266 | $8,124,000 | 2.44% |
| BARINGTON CAPITAL GROUP, L.P. | 24,200 | $1,816,000 | 1.88% |
| Sivik Global Healthcare LLC | 100,000 | $7,504,000 | 1.79% |